Latest filing published 03 Jan 2020 for Dianthus Therapeutics, Inc. /DE/, €96k.
Filing timeline
BuySaleInsider track record
John C. Davis Jr.: trading record in brief
John C. Davis Jr. appears in our data through filings on Dianthus Therapeutics, Inc. /DE/ shares, published by SEC (Form 4). We count 10 filings; the first trade dates from 25 June 2018 and the latest from 2 January 2020.
No open-market purchase appears, only 4 sales worth €458k. Outside the open market, there are 5 option exercises. Since January 2020: no purchases and 1 sale on the market.
Most recently, on 3 January 2020, the filings show an option exercise worth €96k in Dianthus Therapeutics, Inc. /DE/. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John C. Davis Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,294 shares@ US$9.4912.8% of flowCommon StockSEC:0001562180-20-000119:0
- 11,294 shares@ US$15.0420.3% of flowCommon StockSEC:0001562180-20-000119:1
- 114 shares@ US$9.490.1% of flowCommon StockSEC:0001562180-19-006220:0
- 805 shares@ US$9.490.9% of flowCommon StockSEC:0001562180-19-006220:1
- 919 shares@ US$15.001.7% of flowCommon StockSEC:0001562180-19-006220:2
- 4,614 shares@ US$9.495.3% of flowCommon StockSEC:0001562180-19-006009:0
- 4,614 shares@ US$15.008.4% of flowCommon StockSEC:0001562180-19-006009:1
- 17,055 shares@ US$9.4919.6% of flowCommon StockSEC:0001562180-19-006009:2
- 17,055 shares@ US$15.0031.0% of flowCommon StockSEC:0001562180-19-006009:3
- 8,304 sharesCommon StockSEC:0000899243-18-018317:0
10 of 10 declarations
